Status:
UNKNOWN
Cardiopulmonary Rehabilitation in COVID-19 Longhaulers
Lead Sponsor:
Noah Greenspan
Collaborating Sponsors:
University of Dayton
Conditions:
Covid19
Viral Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study will test the efficacy of treadmill exercise combined with supplemental oxygen during exercise and recovery for the treatment of persistent post-acute COVID-19 symptoms. Participants will b...
Detailed Description
This study will test the efficacy of a COVID-19 specific cardiopulmonary rehabilitation protocol for treatment of persistent post-acute COVID symptoms and to study the impact of cardiopulmonary improv...
Eligibility Criteria
Inclusion
- Between the ages of 18-60
- Contracted COVID-19 between February - July 2020
- Has been clinician-diagnosed with COVID-19 based on PCR/antigen testing, antibody testing, or clinical symptoms
- Is currently experiencing one or more of the following symptoms, which began only after contracting COVID-19 : dyspnea, cough, chest pain, tachycardia or other arrhythmias, hypertension, hypotension, blood pressure lability, oxygen desaturation, exercise/activity intolerance, fatigue, or dizziness.
- Has been cleared by a physician for exercise and supplemental oxygen.
- Has the capacity to provide written, informed consent
- Able to complete questionnaires in English
Exclusion
- History of any of the following per the American College of Sports Medicine exercise testing guidelines (American College of Sports Medicine et al., 2018) to be determined during a screening consultation:
- Acute myocardial infarction within the past two days
- Ongoing unstable angina
- Uncontrolled cardiac arrhythmias
- Active endocarditis
- Symptomatic severe aortic stenosis
- Decompensated heart failure
- Active pulmonary embolism, pulmonary infarction, or deep venous thrombosis
- Active myocarditis or pericarditis
- Acute aortic dissection
- Physical disability that precludes safe and adequate testing
- Participants who demonstrate orthostatic intolerance or oxygen desaturation (\<90%) during the exercise tolerance test will no longer be eligible for the study because it is not safe for them to exercise on a treadmill.
Key Trial Info
Start Date :
January 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 20 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04898205
Start Date
January 21 2021
End Date
January 20 2022
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Post-COVID Rehabilitation and Recovery Clinic at H&D Physical Therapy
New York, New York, United States, 10017